A Study to Investigate the Safety and Efficacy of Optivate® in Children Under 6 Years of Age With Haemophilia A.

A Study With OPTIVATE® in People With Von Willebrand Disease

NCT00387192 ·Status: TERMINATED ·Phase: PHASE3

A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Under the Age of 6 Years

NCT02263469 ·Status: COMPLETED ·Phase: PHASE3

A Study to Compare the Pharmacokinetics and Safety of Optivate® and Haemate P® in Patients With Von Willebrand Disease.

NCT02250508 ·Status: COMPLETED ·Phase: PHASE2

Optivate in People With Von Willebrand Disease Undergoing Surgery

NCT00404300 ·Status: TERMINATED ·Phase: PHASE3

Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A

NCT02256917 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia A

NCT01125813 ·Status: COMPLETED ·Phase: PHASE3

Clinical Study to Investigate the PK, Efficacy, and Safety of Wilate in Patients With Severe Hemophilia A

NCT02954575 ·Status: COMPLETED ·Phase: PHASE3

Human Cell Line-derived Recombinant Factor VIII (Human-cl-rhFVIII) in Previously Untreated Patients

NCT01712438 ·Status: COMPLETED ·Phase: PHASE3

ADVATE 2 mL Post-Authorization Safety Surveillance (PASS)

NCT02093741 ·Status: COMPLETED

Validation Study of a cOmputer Pharmacokinetic Tool to assIst in the Follow up Care of haeMophilia A Patients

NCT01436825 ·Status: COMPLETED

An Open Study to Investigate the Safety and Efficacy of Replenine®-VF in Severe Haemophilia B Patients

NCT02231944 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery

NCT01561391 ·Status: COMPLETED ·Phase: PHASE4

A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa

NCT02448680 ·Status: COMPLETED ·Phase: PHASE3

A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia A

NCT04158934 ·Status: ACTIVE_NOT_RECRUITING

A Study to Compare the Pharmacokinetics and Safety of Replenine®-VF, Replenine® or Other Factor IX in Haemophilia B

NCT02263456 ·Status: COMPLETED ·Phase: PHASE3

Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A

NCT00306670 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

A Study to Investigate Bio Product Laboratory Ltd (BPL's) Factor X in the Prophylaxis of Bleeding in Children <12 Years

NCT01721681 ·Status: COMPLETED ·Phase: PHASE3

Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants

NCT03876301 ·Status: COMPLETED

Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures

NCT01913405 ·Status: COMPLETED ·Phase: PHASE3

Study of Next-Generation Recombinant Factor IX Variant in Adult Subjects With Hemophilia B

NCT03995784 ·Status: COMPLETED ·Phase: PHASE2

Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure

NCT02846532 ·Status: COMPLETED ·Phase: PHASE3

Study to Investigate the Long-term Efficacy and Safety of Human-cl rhFVIII in Previously Treated Patients (PTPs)

NCT01341912 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A

NCT05987449 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen Deficiency

NCT02408484 ·Status: COMPLETED ·Phase: PHASE3

ADVATE Post Authorization Safety Surveillance

NCT00214734 ·Status: COMPLETED